Urinary tract infections (UTIs) are a serious healthcare dilemma influencing millions of patients every year and represent the second most frequent type of body infection. Pseudomonas aeruginosa is a multidrug-resistant pathogen causing numerous chronic biofilm-associated infections including urinary tract, nosocomial, and medical devices-related infections. In the present study, the biofilm of P. aeruginosa CCIN34519, recovered from inpatients with UTIs, was established on polystyrene substratum and scanning electron microscopy (SEM) and was utilized for visualization of the biofilm. A previously described in vitro system for real-time monitoring of biofilm growth/inhibition was utilized to assess the antimicrobial effects of ciprofloxacin...
Pseudomonas aeruginosa is increasingly resistant to conventional antibiotics, which can be compounde...
Pseudomonas aeruginosa is responsible for 65% of mortality in hospitals all over the world. Its prev...
In vitro models that mimic in vivo host-pathogen interactions are needed to evaluate candidate drugs...
Urinary tract infections (UTIs) are a serious healthcare dilemma influencing millions of patients ev...
Urinary tract infections (UTIs) are a serious healthcare dilemma influencing millions of patients ev...
Pseudomonas aeruginosa is the second most common pathogen responsible for nosocomial urinary tract i...
Pseudomonas aeruginosa has gained increasing significance as opportunistic pathogens in hospitalised...
Emerging Human Infections (The Ohio State University Denman Undergraduate Research Forum)Pseudomonas...
International audiencePseudomonas aeruginosa causes urinary tract infections associated with cathete...
Pseudomonas aeruginosa is a leading cause of disease and death particularly in cystic fibrosis patie...
In order to investigate the hypothesis that the combination of clarithromycin with other antibacteri...
Ulifloxacin is the active form of the prodrug prulifloxacin and shows a highly potent antipseudomona...
Public health is facing a new challenge due to the alarming increase in bacterial resistance to most...
Within recent years there have been a growing number of antibiotic resistant bacterial strains. Many...
Abstract Microbial biofilms are formed in a variety of clinical situations and increase antibiotic r...
Pseudomonas aeruginosa is increasingly resistant to conventional antibiotics, which can be compounde...
Pseudomonas aeruginosa is responsible for 65% of mortality in hospitals all over the world. Its prev...
In vitro models that mimic in vivo host-pathogen interactions are needed to evaluate candidate drugs...
Urinary tract infections (UTIs) are a serious healthcare dilemma influencing millions of patients ev...
Urinary tract infections (UTIs) are a serious healthcare dilemma influencing millions of patients ev...
Pseudomonas aeruginosa is the second most common pathogen responsible for nosocomial urinary tract i...
Pseudomonas aeruginosa has gained increasing significance as opportunistic pathogens in hospitalised...
Emerging Human Infections (The Ohio State University Denman Undergraduate Research Forum)Pseudomonas...
International audiencePseudomonas aeruginosa causes urinary tract infections associated with cathete...
Pseudomonas aeruginosa is a leading cause of disease and death particularly in cystic fibrosis patie...
In order to investigate the hypothesis that the combination of clarithromycin with other antibacteri...
Ulifloxacin is the active form of the prodrug prulifloxacin and shows a highly potent antipseudomona...
Public health is facing a new challenge due to the alarming increase in bacterial resistance to most...
Within recent years there have been a growing number of antibiotic resistant bacterial strains. Many...
Abstract Microbial biofilms are formed in a variety of clinical situations and increase antibiotic r...
Pseudomonas aeruginosa is increasingly resistant to conventional antibiotics, which can be compounde...
Pseudomonas aeruginosa is responsible for 65% of mortality in hospitals all over the world. Its prev...
In vitro models that mimic in vivo host-pathogen interactions are needed to evaluate candidate drugs...